DUBAI, UAE, Oct. 25, 2021 /PRNewswire/ -- ATFX recently attended the iFX Expo held in Limassol, Cyprus, from 4-6 October 2021.
Ultimate Fintech organizes the B2B fintech expo to connect top-level executives from companies operating in the FX and fintech sectors.
The expo features executives from leading companies in the technology and liquidity sectors, digital assets and blockchain sectors, retail and institutional brokers, etc.
ATFX participated in the expo via its ATFX Connect fintech arm that primarily targets institutional clients.
The broker's executives were delighted to participate in the event and connect with other top-level executives from FX and fintech firms.
ATFX Connect, the institutional arm of ATFX, focusing on Hedge Funds, Family Offices, B2B, Asset Managers, HNW's, and spread betting accounts, has reported a quarterly growth of over 30% for its trading volumes for Q1 2021 and Q2 2021.
ATFX Connect supports institutional clients by providing them with Direct Market access to liquidity from T1 bank and non-bank providers in Spot FX, Precious Metals and CFDs. In addition, the flexible infrastructure enables ATFX to manage aggregation, pricing and allows integration with any third-party platform.
Data I/O Corporation , the leading global provider of advanced security and data deployment solutions for microcontrollers, security ICs and memory devices, today announced financial results for the first quarter ended March 31, 2024.
First Quarter...
SkyWest, Inc. ("SkyWest") today reported financial and operating results for Q1 2024, including net income of $60 million, or $1.45 per diluted share, compared to net loss of $22 million, or $0.45 loss per share, for Q1 2023.
Commenting on the...
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first...
Bruker Corporation today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current...
Gilead Sciences, Inc. announced today its first quarter 2024 results of operations.
"Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, Oncology and...
